Stock Analysis: Guizhou Bailing Group Pharmaceutical
Company: Guizhou Bailing Group Pharmaceutical Company Limited
Bloomberg ticker: 002424 SZ
Market cap: US$1,163m
Background: Guizhou Bailing Group Pharmaceutical Company Limited is a Chinese company specializing in the research, production, and sale of traditional Chinese and Miao ethnic medicines. It operates primarily within China and is known for its Miao medicine products like Yindan XinnaoTong Softgels.
World Class Benchmarking of Guizhou Bailing Group Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 6 was same compared to the prior period’s 6th rank
- This is below average performance compared to 310 medium Health Care companies worldwide
- Profitability rank of 8 was worse than its Growth rank of 2
- Profitability rank of 8 was the same compared to the prior period’s 8th rank
- This is below average performance compared to peers
- Growth rank of 2 was the same compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
More By This Author:
Stock Analysis: Karmarts
Stock Analysis: Astra Agro Lestari
Stock Analysis: Golden Agri-Resources
Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...
more